Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of pentoxifylline and tacrolimus in the treatment of vitiligo patients
IRCT20120909010795N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2017
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline and tacrolimus in Vitiligo (2 arms), sponsored by Shiraz University of Medical Sciences. Started Aug 2017; status: completed.
02
Drugs
pentoxifyllinetacrolimus
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20120909010795N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120909010795N3.